Metadaten| Author: | Elisabeth AdamORCiDGND, Benedikt SchmidORCiDGND, Michael SonntagbauerGND, Peter KrankeGND, Kai ZacharowskiORCiDGND, Patrick MeybohmORCiDGND |
|---|
| URN: | urn:nbn:de:hebis:30:3-757196 |
|---|
| DOI: | https://doi.org/10.1186/s13054-020-03293-8 |
|---|
| ISSN: | 1466-609X |
|---|
| Parent Title (English): | Critical care |
|---|
| Publisher: | BioMed Central ; Springer |
|---|
| Place of publication: | London ; Berlin ; Heidelberg |
|---|
| Document Type: | Article |
|---|
| Language: | English |
|---|
| Date of Publication (online): | 2020/09/24 |
|---|
| Date of first Publication: | 2020/09/24 |
|---|
| Publishing Institution: | Universitätsbibliothek Johann Christian Senckenberg |
|---|
| Release Date: | 2024/01/24 |
|---|
| Tag: | COVID-19; Critical care; Immunomodulatory agents; Pulmonary edema; Respiratory distress syndrome; Therapies; adult; investigational |
|---|
| Volume: | 24 |
|---|
| Issue: | art. 574 |
|---|
| Article Number: | 574 |
|---|
| Page Number: | 4 |
|---|
| First Page: | 1 |
|---|
| Last Page: | 4 |
|---|
| Note: | The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request. |
|---|
| Note: | This study was funded by institutional funds of both University hospitals. FX06 was provided by the manufacturer (F4 Pharma, Vienna, Austria). No further external funding, especially none through the pharmaceutical manufacturer, was provided. The Universities of Frankfurt and Wuerzburg are in part owners of the patent of FX06. Open Access funding enabled and
organized by Projekt DEAL. |
|---|
| HeBIS-PPN: | 517910047 |
|---|
| Institutes: | Medizin |
|---|
| Dewey Decimal Classification: | 6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit |
|---|
| Sammlungen: | Universitätspublikationen |
|---|
| Licence (German): |  Creative Commons - CC BY - Namensnennung 4.0 International |
|---|
